维普中文期刊产品整合服务
159篇 您的检索式:作者名="Lai AS"
    题名 作者 年代 出处 被引量
1恩替卡韦与拉米夫定治疗HBeAg阴性慢性乙型肝炎的对照研究显示文摘Ⅱ期临床试验已经证实恩替卡韦是一种治疗HBeAg阴性慢性乙型肝炎有效和可选择的抗病毒药物。采用双盲法将648例未曾接受过核苷类药物治疗的HBeAg阴性慢性乙型肝炎随机分配进入恩替卡韦(0.5mg/d)治疗组或拉米夫定(100mg/d)治疗组,疗程至少52wk。Lai CL Shouval D Lok AS 陈楠(摘译) 张占卿(审校) 2006世界感染杂志2006,6,4:197
2TrkB phosphorylation by Cdk5 is required for activity-dependent structural plasticity and spatial memory显示文摘Lai KO Wong AS Cheung MC 2012Nat Neurosci2012,15,11:1
3Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection显示文摘Lok AS Lai CL Wu PC Leung EK Lam TS 1987Gastroenterology1987,92,6:1
4Long-term safety of lamivudine treatment in patients with chronic hepatitis B 显示文摘Lok AS Lai CL Leung N 2003Gastroenterology2003,125,6:1
5Efficacy and safety of the Ahmedglaueoma valve implant in Chinese eyes with complicated glaucoma 显示文摘Lai JS Poon AS Chua JK 2000Br J Ophthalmol2000,84,7:1
6Efficacy and safety of the Ahmed glaucoma valve implant in Chinese eyes with complicated glaucoma显示文摘Lai JS Pooh AS Chua JK 2000Br J Ophthalmol2000,84,7:1
7Long-term safety of lamivudlne treatment in patients with chronic hepatitis B 显示文摘Lok AS Lai CL leung N 2003Gastroenterology2003,125,6:1
8Bicycle helmets: head im-pact dynamics in helmeted and unhelmeted oblique impacttests 显示文摘Mcintosh AS Lai A Schilter E 2013Traffic Injury Prev2013,14,5:1
9Characteristic uptake pattern of bone scintigraphy in patients with hepatocellular carcinoma following treatment with high-intensity focused ultrasound 显示文摘Ma WH Ho WY Lai AS 2013Nuel Med Mol Imaging2013,47,4:1
10Long-term safety of lamivudine treatment in patients with chronic hepatitis B显示文摘Lok AS Lai CL Leung N 2003Gastroenterology2003,125,6:1
11Interleukin-5 messenger RNA expression in peripheral blood CD^+4 cells in asthma显示文摘Lai CK Ho AS Chen CH 1996J Allergy Clin Immunol1996,97,6:1
12Long-term safety of lamivudine treatment in patients with chronic hepatitis B显示文摘Lok AS Lai CL Leung N 2003Gastroenterology2003,125,:1
13A controlled trial of interferon with or without prednisone priming for chronic hepatitis B显示文摘Lok AS Wu PC Lai CL 1992Gastroenterology1992,102,6:1
14Long-term safety of lsmivudine treatment in patients with chronic hepatitis B显示文摘Lok AS Lai CL Leung N 0,,06:1
15Cross-validation study of class Ⅲ beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials显示文摘Reiman T Lai R Veillard AS 2012Ann Oncol2012,23,1:1
16Biological principles of microRNA-mediated regulation : shared themes amid diversity显示文摘Flynt AS Lai EC 2008Nat Rev Genet2008,9,11:1
17Overexpression of p53 in hepatocellular carcinoma: A clinicopathological and prognostic correlation显示文摘Ng IO Lai EC Chan AS 1995J Gastroenterol Hepatol1995,10,3:1
18Long-term safety of lamivudine treatment in patients with chronic hepatitis B显示文摘LOK AS LAI CL LEUNG N 2003Gastroenterology2003,125,6:1
19Long-term safety of lamivudine treatment in patients with chronic hepatitis B显示文摘Lok AS Lai CL Leung N 2003Gastroenterology2003,125,:1
205-year follow-up of 998 chronic hepatitis B patients to determine long-term safety of lamivudine and clinical consequences of lamivudine resistant mutations显示文摘Lok AS Lai CL Leung N 2003Hepatology2003,38,4:1
返回顶部 每页显示:
共8页 首页 上一页 第1页 下一页 末页 /8 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费